HepaRG Advantage Biopredic International is the exclusive worldwide licensor of HepaRG, a human hepatic stem cell model. This asset can be positioned to CROs, pharma and cosmetics labs seeking human relevant liver models for metabolism, toxicology and transporter studies. Propose joint marketing, licensing collaborations and bundled HepaRG services to accelerate client acquisition.

Toxicology Demand The portfolio targets toxicology, genotoxicity, metabolism and transporter analysis, aligning with demand from pharma, chemical and cosmetic safety testing. Sell comprehensive study packages that combine core cell products such as hepatocytes, microsomes and S9 fractions with assay services and data interpretation to streamline regulatory submissions.

Partner Ecosystem Past partnerships with ScitoVation, Visikol and Science Exchange show openness to collaborations and outsourcing models. Build on this by expanding to more CRO networks, academia alliances and organ model providers to create integrated workflows that include Biopredic cells with third party platforms.

Europe Growth Based in France with global customer reach, there is opportunity to scale through distributors and regional sales teams. Focus on EU pharma, cosmetics and academic labs; offer training, technical support and regulatory ready kits to ease adoption in new markets.

Cross Sell Biopredic already offers a range of tissues, cells and biofluids across liver, skin and blood products. Create cross sell campaigns to existing customers for multi tissue toxicology panels, or bundled testing services combining liver cells with skin discs or immune cells to address cross cutting safety and efficacy studies.